Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Reexamination Certificate
2005-03-15
2005-03-15
Jones, Dameron L. (Department: 1616)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
C424S001110, C424S001650, C424S009100, C530S300000, C530S317000, C530S327000
Reexamination Certificate
active
06866837
ABSTRACT:
Compounds and methods for the diagnosis and treatment of tumors, including breast and prostate tumors and metastases thereof using radiolabelled peptides that bind to GRP receptors. The peptides are Bombesin analogs wherein the first and optionally the third amino acid are modified.
REFERENCES:
patent: 5686410 (1997-11-01), Albert et al.
patent: 6200546 (2001-03-01), Hoffman et al.
patent: 0103558 (1984-03-01), None
patent: 0259904 (1991-06-01), None
patent: 0243929 (1995-09-01), None
patent: WO 8902752 (1989-04-01), None
patent: WO 9003798 (1990-04-01), None
patent: WO 9101144 (1991-02-01), None
Breeman, et al., [111In-DTPA0, Pro1, Tyr4] bombesin: Studies In Vitro and in Rats, The Journal of Nuclear Medicine, vol. 39 (Jun. 9, 1998), p. 62P, Society of Nuclear Medicine, U.S.A. abstract No. 239.
Hoffman, Li, Sieckman, and Volkert, Uptake and Retention of a Rh-105 Labeled Bombesin Analogue in GRP Receptor Expressing Neoplasms: An In Vitro Study, The Journal of Nuclear Medicine, vol. 38 (May 1997 Supplement), pp. 188P-189P, Society of Nuclear Medicine, U.S.A. abstract No. 808.
Hoffman, Sieckman, and Volkert, Iodonated Bombesin Analogues: Effect of N-Terminal vs Side Chain Iodine Attachment on BBN/GRP Receptor Binding, The Journal of Nuclear Medicine, vol. 37 (May 1996 Supplement), p. 185P, Society of Nuclear Medicine, U.S.A. abstract No. 850.
Baidoo, et al., Synthesis and Evaluation of High Affinity Technetium Bombesin Analogs, The Journal of Nuclear Medicine, vol. 38 (May 1997 Supplement), p. 87P, Society of Nuclear Medicine, U.S.A. abstract No. 323.
Zinn, Buchsbaum, et al., Imaging Adenoviral-Mediated Gene Transfer of Gastrin Releasing Peptide Receptor (GRPr) Using a Tc-99m-Labeled Bombesin (BBN) Analogue, The Journal of Nuclear Medicine, vol. 39 (May 1998 Supplement), p. 224P-225P, Society of Nuclear Medicine, U.S.A. abstract No. 974.
Hoffman, Li, Volkert, Sieckman, Higginbotham and Ochrymowycz, Synthesis and Characterization of Rh-105 Labelled Bombesin Analogues: Enhancement of GRP Receptor Binding Affinity Utilizing Aliphatic Carbon Chain Linkers, The Jounal of Labelled Compound and Radiopharmaceuticals, vol. 40 (1997), pp. 490-492, John Wiley & Sons, Inc., U.S.A.
Breeman et al, In Vitro and In Vivo Studies of Substance P Receptor Expression in Rats with the New Analog [indium-111-DTPA-Arg1] Substance P, The Journal of Nuclear Medicine, vol. 37, (1996), p. 61P, Society of Nuclear Medicine, U.S.A.
Rogers, Curiel, Laffoon, and Buchsbaum, Synthesis and Radiolabeling of Bombesin Derivatives with Copper-64 and Binding to Cells Expressing the Gastrin Releasing Peptide Receptor, The Journal of Labelled Compounds and Radiopharmaceuticals, vol. 40 (1997), p. 482, John Wiley & Sons, Inc., U.S.A.
Safavy, Khazaeli, Qin and Buchsbaum, Synthesis of Bombesin Analogues for Radiolabeling with Rhenium-188, Cancer, vol. 80 (1997), pp. 2354-2359, American Cancer Society, U.S.A.
Rogers, et al., Tumor Localization of a Radiolabeled Bombesin Analog in Mice Bearing Human Ovarian Tumors Induced to Express GRP Receptor by an Adenoviral Vector, Cancer, vol. 80 (1997), pp. 2419-2424, American Cancer Society, U.S.A.
Rogers, Buchsbaum, et al., Localization of I-125-mIP-Des-Met14-bombesin (7-13) NH2in Ovarian Carcinoma Induced to Express GRP Receptor by an Adenoviral Vector, Cancer, vol. 80 (1997), pp. 2419-2424, American Cancer Society, U.S.A.
M. E. Rosenfeld, et al., Adenoviral Mediated Delivery of Gastrin-releasing Peptide Receptor Results in Specific Tumor Localization of a Bombesin Analogue In Vivo, Clinical Cancer Research, vol. 3 (Jul. 1997), pp. 1187-1194, American Association for Cancer Research, U.S.A.
Hoffman, et al., Rh-105 Bombesin Analogs: Selective In Vivo Targeting of Prostrate Cancer with a Therapeutic Radionuclide, The Journal of Nuclear Medicine, vol. 39, (1998), p. No. 982, Society of Nuclear Medicine, U.S.A. (abstract No. 882).
Schibli, Hoffman, Volkert, et al., A Tc-99m DITHIA-DI (Bis-Hydroxymethylene) Phosphine Conjugate of Bombesin: In Vitro and In Vivo Studies, The Journal of Nuclear Medicine, vol. 39 (May 1998 Supplement), p. 225P, Society of Nuclear Medicine, U.S.A. abstract No. 987.
Hoffman, Sieckman & Volkert, Targeting Small Cell Lung Cancer Using Iodinated Peptide Analogs, The Journal of Labelled Compound and Radiopharmaceuticals, vol. 37, (1995), pp. 321-325, John Wiley & Sons, Inc., U.S.A.
Halmos, Wittliff and Schally, Characterization of Bombesin/Gastrin-releasing Peptide Receptors in Human Breast Cancer and Their Relationship to Steroid Receptor Expression, Cancer Research, vol. 55, (Jan. 15, 1955) pp. 280-287, American Association of Cancer Research, U.S.A.
Breeman Wout A.
Reubi Jean-Claude
Srinivasan Ananthachari
Blackwell Sanders Peper Martin LLP
Jones Dameron L.
Mallinckrodt Inc.
LandOfFree
Radiolabeled peptides for the diagnosis and treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiolabeled peptides for the diagnosis and treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiolabeled peptides for the diagnosis and treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3437768